Recent Finacing
Recent Raise
Heparinex develops heparosan-based conjugation and production technologies—bacterial fermentation and in vitro polymer synthesis—to create non-animal heparinoid drug-delivery and biomaterial formulations for therapeutic, medical-device, cosmetic, and ophthalmic applications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor